l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Objective The authors conducted two multicenter sequential parallel comparison design trials to investigate the effect of L-methylfolate augmentation in the treatment of major depressive disorder in patients who had a partial response or no response to selective serotonin reuptake inhibitors (SSRIs). Method In the first trial, 148 outpatients with SSRI-resistant major depressive disorder were enrolled in a 60-day study divided into two 30-day periods. Patients were randomly assigned, in a 2:3:3 ratio, to receive L-methylfolate for 60 days (7.5 mg/day for 30 days followed by 15 mg/day for 30 days), placebo for 30 days followed by L-methylfolate (7.5 mg/day) for 30 days, or placebo for 60 days. SSRI dosages were kept constant throughout the study. In the second trial, with 75 patients, the design was identical to the first, except that the l-methylfolate dosage was 15 mg/day during both 30-day periods. Results In the first trial, no significant difference was observed in outcomes between the treatment groups. In the second trial, adjunctive L-methylfolate at 15 mg/day showed significantly greater efficacy compared with continued SSRI therapy plus placebo on both primary outcome measures (response rate and degree of change in depression symptom score) and two secondary outcome measures of symptom severity. The number needed to treat for response was approximately six in favor of adjunctive L-methylfolate at 15 mg/day. L-Methylfolate was well tolerated, with rates of adverse even…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Folate has been studied in a placebo-controlled trial an adjunctive treatment to fluoxetine, with significantly greater improvement in the folate group, a difference most pronounced in women [43].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
In the citing paper
“94% of women who received fluoxetine with the addition of folate 500 mcg per day were treatment responders, compared to 61% of those who received fluoxetine and placebo.”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [43]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Self-citationFava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Self-citationEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies
Bauer, M., & Döpfmer, S. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00006 · Cited by 304
Research works printed but not linked: 3
- 10.3109/10401230209147396 · doi:10.3109/10401230209147396 · Paper page
- Passeri M, 1993, Aging (Milano), 5, 63
- First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders With Psychotic Screen (SCID-I/P w/ Psychotic Screen) Version 2.0
Cited by
Items 101–200 of 285
Pan, L. A., Segreti, A. M., Wrobleski, J., Shaw, A., Hyland, Κ., Hughes, M. A., Finegold, D. N., Naviaux, R. K., Brent, D. A., Vockley, J., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722003233 · Cited by 23
The Potential Utility of Pharmacogenetic Testing in Psychiatry
Gardner, K. R., Brennan, F. X., Scott, R., & Lombard, J. (2014) · Psychiatry Journal · doi:10.1155/2014/730956 · Cited by 26
Najjar, S., Pearlman, D. M., Hirsch, S., Friedman, K., Strange, J., Reidy, J., Khoukaz, M., Ferrell, R. B., Devinsky, O., Najjar, A., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.041 · Cited by 24
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders
Maruf, A. A., Poweleit, E. A., Brown, L. C., Strawn, J. R., & Bousman, C. (2021) · Pharmacopsychiatry · doi:10.1055/a-1681-2047 · Cited by 22
Frazier, E. A., Gracious, B., Arnold, L. E., Failla, M. L., Chitchumroonchokchai, C., Habash, D., & Fristad, M. A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0098 · Cited by 23
Chávez-Castillo, M., Nava, M., Ortega, Á., Rojas, M., Núñez, V., Salazar, J. J., Bermúdez, V., & Rojas, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200413144401 · Cited by 24
Treatment Resistant Depression: Strategies for Primary Care
Preston, T. C., & Shelton, R. C. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0370-7 · Cited by 23
Self-citationSmith, T., Sharp, S., Manzardo, A. M., & Butler, M. G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034416 · Cited by 21
“This variant impacts monoamine and catecholamine production [19–26] and associated with depression.”
BackgroundWhat is the Role of Alternative Treatments in Late-life Depression?
Nyer, M., Doorley, J. D., Durham, K. E., Yeung, A., Freeman, M. P., & Mischoulon, D. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.08.012 · Cited by 26
“A recent study on 5-MTHF (Deplin) supports efficacy as an antidepressant adjunct at doses of 15 mg/d.(32) This form may be particularly effective because it crosses the”
Self-citationThe Evolving Story of Folate in Depression and the Therapeutic Potential of l -Methylfolate
Nelson, J. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12091207 · Cited by 21
Beer, C., Rae, F., Semmler, A., & Voisey, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147992 · Cited by 20
“In a study on SSRI-resistant major depressive disorder, 148 patients were randomly assigned to receive L-methylfolate, placebo followed by L-methylfolate, or placebo for 60 days [60].”
MethodSarris, J. J., Stough, C. K. K., Bousman, C., Murphy, J., Savage, K. M., Smith, D. J., Menon, R., Chamoli, S., Oliver, G., Berk, M., et al. (2015) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2015.02.001 · Cited by 19
Self-citationDar, S. A., Wani, R. A., & Haq, I. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09892-0 · Cited by 21
Zhang, Z., Wu, H., Qi, S., Tang, Y., Qin, C., Liu, R., Zhang, J., Cao, Y., & Gao, X. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416426 · Cited by 19
“The potential benefits of 5-MTHF for neuropathy in depressive patients [16] have been reported, but to the best of our knowledge, little is known about its impact on AD.”
BackgroundSepehrmanesh, Z., Omidi, A., & Gholampoor, N. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.33243 · Cited by 19
“late is an effective adjunctive therapy in the treatment of patients with MDD that is resistant to SSRIs (23).”
BackgroundOptimized Treatment Strategy for Depressive Disorder
Chen, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_11 · Cited by 23
Antidepressant efficacy and side effect burden: an updated guide for clinicians
Kutzer, T., Dick, M., Scudamore, T., Wiener, M., & Schwartz, T. L. (2020) · Drugs in Context · doi:10.7573/dic.2020-2-2 · Cited by 19
Plasma homocysteine concentrations and depression: A twin study
Bremner, J. D., Goldberg, J. H., & Vaccarino, V. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100087 · Cited by 22
“Studies in patients with depression showed that folate and/or Vitamin B-12 including as an augmentation to antidepressants resulted in improved symptoms of depression in some studies (Coppen and Bailey, 2000; Kwok et al., 2019; Mech and Farah, 2016; Papakostas et al., 2012; Resler et al., 2008) but not others (Almeida…”
ResultA sequential enriched design for target patient population in psychiatric clinical trials
Chen, Y., Zhang, X., Tamura, R., & Chen, C. M. (2014) · Statistics in Medicine · doi:10.1002/sim.6116 · Cited by 16
The Role of Brain Barriers in Maintaining Brain Vitamin Levels
Tiani, K. A., Stover, P. J., & Field, M. S. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124235 · Cited by 16
Biology of Perseverative Negative Thinking: The Role of Timing and Folate Intake
Eszlári, N., Bruncsics, B., Millinghoffer, A., Hullám, G., Petschner, P., Gonda, X., Breen, G. D., Antal, P., Bagdy, G., Deakin, J. F. W., et al. (2021) · Nutrients · doi:10.3390/nu13124396 · Cited by 15
“Although results are contradictory [17], folate has been found to be an effective and safe adjuvant antidepressant treatment for major depressive disorder [18,19], especially at a dose of <5 mg/day (or 15 mg/day in case of methylfolate) and as an adjunct to selective serotonin reuptake inhibitor therapy [20].”
BackgroundClinton, S. M., Shupe, E. A., Glover, M. E., Unroe, K. A., McCoy, C. R., Cohen, J. L., & Kerman, I. A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15158 · Cited by 18
“…generally consistent with findings in depressed patients showing that treatment with DNA methylation- promoting agents improves depressive symptoms (Papakostas et al., 2012; Papakostas, Shelton, et al., 2012), and highlights epigenetic mechanisms that may contribute to individual differences in…”
ResultKey considerations in the pharmacological management of treatment-resistant depression
Yavi, M., Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1951225 · Cited by 15
“Another agent of interest as an augmentation strategy is levomethylfolate, given its role in monoamine synthesis and findings of lower levels of folate derivatives in patients with inadequate antidepressant response [57].”
BackgroundAdjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J. J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16304 · Cited by 15
“…studies are combined, when the only methyl-folate randomized controlled trial with available baseline and end-point data (Papakostas et al. [24] trial 1/phase 1: 7.5 mg; trial 2/phase 1: 15mg)wasaddedtothemeta-analysis, a similar nonsigni fi cant effect was revealed (p 5 0.25; z 5 1.15, 95%…”
InfluentialSelf-citationVitamin B Supplementation: What's the Right Choice for Your Patients?
Leahy, L. G. (2017) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20170619-02 · Cited by 19
Can precision medicine advance psychiatry?
Roche, D., & Russell, V. (2020) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2020.79 · Cited by 16
Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-α
Budni, J., Moretti, M., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113512 · Cited by 15
Dünner, D. L. (2014) · PubMed Central · doi:10.11919/j.issn.1002-0829.214177 · Cited by 16
“Other compounds may also be useful as adjunctive treatment for antidepressants that are only partially effective, including lithium carbonate, thyroid preparations, alpha methyl folate, and others.([7,8])”
BackgroundPharmacogenomics in Psychiatric Practice.
El-Mallakh, R., Roberts, R. J., El-Mallakh, P., Findlay, L. J., & Reynolds, K. K. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.05.001 · Cited by 14
Clinical utility of pharmacogenetics-guided treatment of depression and anxiety
Boland, J. R., Duffy, B. C., & Myer, N. M. (2017) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2017.11.001 · Cited by 13
Freeman, M. P., Savella, G. M., Church, T. R., Góez-Mogollón, L. M., Sosinsky, A. Z., Noe, O. B., Kaimal, A., & Cohen, L. S. (2019) · Annals of Clinical Psychiatry · doi:10.1177/104012371903100107 · Cited by 13
Ntasi, G., Tsarbopoulos, A., Mikros, E., & Gikas, E. E. (2021) · Metabolites · doi:10.3390/metabo11070416 · Cited by 12
“5-Methyltetrahydrofolate has been used as a complementary treatment in the case of selective serotonin reuptake inhibitor (SSRI) treatment of severe depression [14,15] with obesity being a co-morbidity factor [16,17].”
MethodDiscovering the Potential Value of Coenzyme Q10 as an Adjuvant Treatment in Patients With Depression
Majmasanaye, M., Mehrpooya, M., Amırı, H., & Eshraghi, A. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001845 · Cited by 11
L-Methylfolate Calcium Supplementation in Adolescents and Children: A Retrospective Analysis
Rainka, M. M., Aladeen, T. S., Westphal, E. S., Meaney, J., Gengo, F. M., Gréger, J., & Capote, H. A. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000400 · Cited by 11
“Prevalence of specific MTHFR mutations 1298AC (heterozygous) genotype 68 (47) 23 (52) 1298CC (homozygous mutant) genotype 7 (5) 3 (7) 677CT (heterozygous) genotype 75 (51) 20 (46) 677TT (homozygous mutant) genotype 27 (18) 5 (11) 1298AC and 677CC genotype combination 32 (22) 16 (36) 1298AC and 677CT genotype combinati…”
Gerbasi, M. E., Eldar‐Lissai, A., Acaster, S., Fridman, M., Bonthapally, V., Hodgkins, P., Kanes, S., & Meltzer-Brody, S. E. (2020) · Archives of Women s Mental Health · doi:10.1007/s00737-020-01042-y · Cited by 12
“The 17-item Hamilton Rating Scale for Depression (HAMD-17) is widely used as a primary endpoint in major depressive disorder (MDD) and PPD clinical trials and is commonly required by regulatory bodies (e.g. Clayton et al. 2015; Hantsoo et al. 2014; Papakostas et al. 2012).”
MethodNutraceutical Augmentation Strategies for Depression: A Narrative Review
Lande, R. G. (2020) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2020.019 · Cited by 13
Targum, S. D., BURCH, D. J., Asgharnejad, M., Petersen, T., Goméni, R., & D, M. F. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.003 · Cited by 10
Jha, S., Kumar, P., Kumar, R., & Das, A. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.05.007 · Cited by 11
Enhancement of recovery from mental illness with l -methylfolate supplementation
Martone, G. (2017) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12227 · Cited by 11
Novel Augmentation Strategies in Major Depression.
Martiny, K. (2017) · PubMed · Cited by 12
Methylfolate as Adjunctive Treatment in Major Depression
Reynolds, E. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13010084 · Cited by 10
Novel Therapeutic Targets for Major Depressive Disorder
Lazar, M. A., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00034-2 · Cited by 10
L-Methylfolate in Antidepressant Non-responders: The Impact of Body Weight and Inflammation
Macaluso, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.840116 · Cited by 10
A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult
Blaszczyk, A. T., Mathys, M. L., & Le, J. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01051-3 · Cited by 9
“Its use in TRD has been seen in younger individuals at a dose of 15 mg/day [126]; however, no studies support its use in TRLLD.”
ResultTrkulja, V., & Barić, H. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_20 · Cited by 11
Targeting Divergent Pathways in the Nutritional Management of Depression
Tobin, D., Vuckovic, A., & Sarris, J. J. (2024) · Nutrients · doi:10.3390/nu16162806 · Cited by 8
Pharmacodynamic Gene Testing in Prader-Willi Syndrome
Forster, J. L., Duis, J. B., & Butler, M. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.579609 · Cited by 8
Controlling Placebo Response in Drug Development: Lessons Learned from Psychopharmacology
Potter, W. Z., Mallinckrodt, C. H., & Detke, M. J. (2014) · Pharmaceutical Medicine · doi:10.1007/s40290-014-0052-8 · Cited by 8
“05 [41–44].”
Javelot, H. (2015) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2015.09.001 · Cited by 9
Methylenetetrahydrofolate Reductase Screening in Treatment-Resistant Depression.
Kandler, C. E., & Lam, S. T. (2019) · PubMed · Cited by 8
Zhang, H., Li, X., Pang, J., Zhao, X., Cao, S., Wang, X., Wang, X., & Li, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00493 · Cited by 8
Frost, R., Zamri, A., Mathew, S., Salame, A., Bhanu, C., Bhamra, S. K., Bazo‐Alvarez, J. C., Heinrich, M., & Walters, K. R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1609605 · Cited by 7
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
Dragic, L., Wegrzyn, E., Schatman, M. E., & Fudin, J. (2017) · Journal of Pain Research · doi:10.2147/jpr.s144560 · Cited by 7
“MTHFR activity is associated with poor or limited response to antidepressants, pain medications, and methylphenidate.(10) Therefore, we hypothesized that PT could benefit from the addition of folate supplementation such as l-methylfolate or lecuovorin for pain, depression, and perhaps ADHD.”
BackgroundInfluentialSuplementação de ácido fólico na gestação e sintomas depressivos pós-parto
Lutz, B. H., Santos, I. S., Domingues, M. R., Murray, J., da Silveira, M. F., Miranda, V. I. A., Silveira, M. P. T., Mengue, S. S., Pizzol, T. D. S. D., & Bertoldi, A. D. (2023) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2023057004962 · Cited by 10
“Folic acid supplements have already been studied as an adjuvant treatment for depression 15,29 , and folic acid rich diets have suggested a reduced risk of depression in some populations 30,31 .”
BackgroundCurrent Role of Herbal and Natural Preparations
Mischoulon, D., & Rapaport, M. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_152 · Cited by 7
Self-citationTreatment resistant depression
Vaccarino, S. R., & Kennedy, S. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00003-4 · Cited by 8
Does folic acid interfere with lamotrigine?
Mischoulon, D., Zajecka, J., Freeman, M. P., & D, M. F. M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30167-5 · Cited by 7
Self-citationМожливості фармакотерапії постінсультної депресії: новий погляд на стару проблему
Burchynskyi, S. H. (2023) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.18.7.2022.977 · Cited by 7
Enrichment designs using placebo nonresponders
Benda, N., & Haenisch, B. (2020) · Pharmaceutical Statistics · doi:10.1002/pst.1992 · Cited by 6
Felger, J. C. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-21054-9_16 · Cited by 6
Abdulrazzaq, Y. M., Shafiullah, M., Kochiyil, J., Padmanabhan, R., & Bastaki, S. M. A. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3285-0 · Cited by 6
“Folate deficiency induced experimentally in animals by folate antagonists or by a folate-deficient diet produces intrauterine growth retardation and congenital malformations, even with a period of deficiency as short as 2 days in early gestation [47] Either 5-methyltetrahydrofolate or folinic acid is very beneficial t…”
BackgroundFoster, S. L., Petrie, S. R., Mischoulon, D., & Fava, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_8 · Cited by 6
Self-citationChapter 6. Single and Broad-Spectrum Micronutrient Treatments in Psychiatric Practice
Popper, C. W., Kaplan, B. J., & Rucklidge, J. J. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378722.lg06 · Cited by 10
Lascar, E. M., Warner, N. M., & Doherty, M. J. (2020) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2020.100419 · Cited by 7
Asadi, M., Riazi, H., Abbasinazari, M., Majd, H. A., & Montazeri, A. (2023) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdad086 · Cited by 5
Zhang, J., Wang, X.-Y., Yang, S., Xu, X., Pan, S.-J., & Li, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.191 · Cited by 5
Complementary and Integrative Health Practices for Depression
Haefner, J. (2017) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20170905-02 · Cited by 6
A commentary on: statistical inference problems in sequential parallel comparison designs
Schoenfeld, D., Doros, G. D., & D, M. F. M. (2019) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2019.1584207 · Cited by 5
Self-citationMoyad, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23422-9_7 · Cited by 5
Neurometabolic approach to treatment-resistant depression
Reynolds, E. H. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.170 · Cited by 5
From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression
Hachmeriyan, A., Panayotova, G. G., & Todorova, H. (2026) · Nutrients · doi:10.3390/nu18091318 · Cited by 4
“…shown benefit in SSRI-resistant depression, with stronger signals in biomarker-and genotype-defined subgroups, supporting the view that folate-related interventions may be most useful in patients with impaired methylation capacity or treatment resistance rather than in unselected populations [21].”
Roberts, S. H., & Tranter, R. (2013) · Evidence-Based Mental Health · doi:10.1136/eb-2013-101269 · Cited by 4
The Use of Natural Products and Supplements in Late-Life Mood and Cognitive Disorders
Varteresian, T. C., Merrill, D. A., & Lavretsky, H. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.15 · Cited by 4
Is augmentation with folate effective for major depressive disorder?
Trincado, J., & Caneo, C. (2018) · Medwave · doi:10.5867/medwave.2018.01.7155 · Cited by 4
Roscizewski, L., Henneman, A., & Snyder, T. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.10.033 · Cited by 4
Bopp, E. A., Poweleit, E. A., Cox, M. O., Farrow, J. E., Strawn, J. R., Durán, L. R. P., Prows, C. A., DelBello, M. P., & Ramsey, L. B. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.039 · Cited by 4
Ahmad, R., & Haque, M. (2024) · Advances in Human Biology · doi:10.4103/aihb.aihb_144_23 · Cited by 4
Li, J., Fei, X., Wang, S., Xu, Z., Xu, F., Wang, J., Gao, Y., & Hu, Y. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s476680 · Cited by 4
Rabjohn, P. (2014) · Psychiatric Annals · doi:10.3928/00485713-20140403-07 · Cited by 4
Evaluation and Treatment Strategies in Patients with Schizophrenia and Comorbid Depression
McRenolds, D., Mehta, P., & Nasrallah, H. A. (2013) · Psychiatric Annals · doi:10.3928/00485713-20131003-05 · Cited by 7
Experimental Therapies for Treatment-Resistant Depression
Jha, M., & Trivedi, M. (2018) · Focus · doi:10.1176/appi.focus.20180013 · Cited by 6
Treatment resistant depression: Challenges and therapeutic choices
Touloumis, C. (2021) · Psychiatriki · doi:10.22365/jpsych.2021.047 · Cited by 4
Köse, S., & Sayar, K. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1552401 · Cited by 4
Arslan, E., & Ordu, M. (2026) · Pharmaceuticals · doi:10.3390/ph19060865 · Cited by 4
“Although L-methylfolate is the biologically active methylated folate form and has recognized CNS relevance, its current evidence base is stronger in psychiatric and monoaminergic contexts than in experimental TBI [32–34].”
Varteresian, T. C., & Lavretsky, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_25 · Cited by 3
Supplements and Natural Remedies for Depression
Mischoulon, D., & Iovieno, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_15 · Cited by 3
Self-citationShea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Chokka, P. R. (2013) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000141 · Cited by 4
“Emerging evidence also supports a role for L-methylfolate supplementation as an adjunct to SSRIs [121].”
BackgroundDépression résistante : les autres stratégies thérapeutiques
Saba, G., Nieto, I., Bation, R., Allaïli, N., Bennabi, D., Molière, F., Richieri, R. M., Holtzmann, J., Bubrovszky, M., Camus, V., et al. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.02.005 · Cited by 3
“Une série de deux études randomisées portant respectivement sur 148 et 75 patients déprimés ne répondant pas ou partiellement à au moins 8 semaines de traitement par ISRS a été réalisée portant sur l'évaluation de l'association au méthylfolate à la posologie de 7,5 ou 15 mg/j [33].”
BackgroundNovel Study Designs for Clinical Trials in Mood Disorders
Jeon, H. J., & Fava, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00008-7 · Cited by 4
Blampied, M., Bell, C., Gilbert, C., Boden, J. M., Nicholls, R. J., & Rucklidge, J. J. (2018) · Medicines · doi:10.3390/medicines5020056 · Cited by 3
“Improvements in mental health symptoms have also been found for various other single nutrient interventions, including folate [37], omega-3 [38], magnesium [39], and zinc [40].”
BackgroundImpact of the MTHFR C677T genetic variant on depression
Lipp, M. A., Pasternak, A. L., & Ward, K. M. (2020) · Current Psychiatry · doi:10.12788/cp.0052 · Cited by 3
Gloor, P., Häberling, I. S., Spanaus, K. S., Kullak-Ublick, G. A., Berger, G. E., & Visentin, M. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.05.012 · Cited by 2
Moraes, J. B., de Oliveira, C. E. C., Alfieri, D. F., VILA, L. M., Euzébio, N. J., Reiche, E. M. V., & Nunes, S. O. V. (2026) · Complex Psychiatry · doi:10.1159/000548757 · Cited by 2
Putz, J. C., Wilding, M., Lackner, S., Narrath, M., Schlotmann, D., Sallmutter, M.-T., Tatzer, J., Brandstätter, A., Lang, J. D., Holasek, S., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350801 · Cited by 2
“This observation is consistent with prior findings linking depression to suboptimal nutritional status, including deficiencies in B vitamins such as folate [89–91].”
The Role of Reproductive Psychiatry in Women’s Mental Health
Dossett, E. C. (2014) · Springer eBooks · doi:10.1007/978-3-319-05116-1_16 · Cited by 3
New Treatment Options for Depression: A Primer for Internists
Byun, T. H., Chaliki, S. S., & Poole, K. G. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.012 · Cited by 4
Pharmacology, Psychopharmacology, and Adverse Drug Reactions
Barnhill, J., Blanco, R. A., Napier, K., & Soda, T. (2023) · Springer eBooks · doi:10.1007/978-3-031-20792-1_44 · Cited by 2
One-pot enzymatic synthesis of l -5-methyltetrahydrofolate from folic acid using enzyme cascades
Zhu, L., Wang, Y., Pan, L., Lin, E., Wang, J., & Chen, X. (2024) · Reaction Chemistry & Engineering · doi:10.1039/d4re00237g · Cited by 2
Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysis
Fidry, M., Zugliani, M. M., do Cabo, M. C., Martins, R. M., Gomez, M. A., Faria, C. G. F., Nardi, A. E., & Freire, R. C. R. (2024) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/0117450179337258241031035148 · Cited by 2
Metadata
- Authors
- Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., Pencina, M., Meisner, A., Bottiglieri, T., Nelson, E., Mischoulon, D., Alpert, J. E., Barbee, J. G., Zisook, S., & Fava, M.
- Affiliations
- Boston University (US)
- From the Center for Treatment-Resistant Depression, Depression Clinical and Research Program, the Biostatistics Center, and the Clinical Trials Network and Institute, Massachusetts General Hospital, Boston; Harvard Medical School, Boston; the Harvard Clinical Research Institute, Boston; the Department of Biostatistics, Boston University, Boston; the Department of Psychiatry, Vanderbilt University School of Medicine, Nashville; Rush University Medical Center, Chicago; the Department of Psychiatry,...
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2012-12
- Volume
- 169
- Issue
- 12
- Pages
- 1267-1274
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2136722242
- Cited by
- 275
- References
- 36
- Citations by year
- 2026: 21 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 18 · 2019: 22 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 26 · 2014: 25 · 2013: 25 · 2012: 1
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- 5-methyltetrahydrofolate, major depressive disorder, selective serotonin reuptake inhibitors, adjunctive therapy, treatment-resistant depression, antidepressant augmentation, response rate, adverse events, folic acid supplementation
- MeSH terms
- Major Depressive Disorder, Depressive Disorder, Major, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Tetrahydrofolates, Treatment Outcome, Chemotherapy, Adjuvant, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.